인공수정 시장 규모, 점유율, 성장 분석 : 유형별, 공급원별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Artificial Insemination Market size was valued at USD 2.38 Billion in 2024 and is poised to grow from USD 2.57 Billion in 2025 to USD 4.75 Billion by 2033, growing at a CAGR of 8.01% during the forecast period (2026-2033).

The artificial insemination market is experiencing significant growth driven by a rising demand for assisted reproductive technologies and an increasing prevalence of infertility issues. Lifestyle changes and medical conditions like endometriosis and PCOS have heightened the need for these techniques. The growing acceptance and accessibility of artificial insemination in developing regions further bolster market expansion. Innovations such as advanced sperm and egg selection methods, alongside cryopreservation and pre-implantation genetic testing, are also propelling development. Additionally, the acceptance of same-sex marriage, LGBT parenting, and the availability of donor gametes contribute to market dynamics. Enhanced policies, increasing awareness, educational initiatives on infertility and artificial insemination, insurance coverage, and a trend toward delayed childbearing are further fueling demand in this evolving sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Artificial Insemination market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Artificial Insemination Market Segments Analysis

The Global Artificial Insemination Market is segmented into Type, Source Type, End Use, and Region. Based on Type, the market is segmented into Intrauterine, Intracervical, Intravaginal, and Intratubal. Based on Source Type, the market is segmented into AIH-Husband and AID-Donor. Based on End Use, it is segmented into Fertility Clinics & Other Facilities, and Home. Based on Region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Artificial Insemination Market

The rising global infertility rates are significantly driving the demand for the artificial insemination market. As delayed conception, shifting lifestyles, environmental factors, and increasing reproductive health disorders become more prevalent, artificial insemination emerges as a crucial solution for couples and individuals facing challenges in achieving natural conception. Assisted reproductive technology serves as a vital option, enabling those struggling with infertility to explore new possibilities. Additionally, growing awareness and acceptance of fertility treatments, coupled with heightened interest in advanced reproductive methods, further enhance the adoption of artificial insemination, fostering market growth in response to these pressing needs.

Restraints in the Artificial Insemination Market

The artificial insemination market faces significant challenges due to the high costs associated with treatment procedures, medications, and related medical expenses, which can make these services unaffordable for many individuals and couples, particularly in areas where insurance coverage for infertility treatments is inadequate. This financial barrier disproportionately affects lower-income populations, limiting their access to reproductive health options. To address this issue and improve accessibility, it is crucial to pursue strategies aimed at reducing costs and enhancing affordability. By implementing measures that alleviate the financial burden, a broader demographic can benefit from artificial insemination services.

Market Trends of the Artificial Insemination Market

The Artificial Insemination market is witnessing a robust trend towards the increased utilization of innovative reproductive technologies that enhance conception rates while minimizing invasiveness. Techniques such as advanced genetic screening, cryopreservation, and high-tech sperm processing are revolutionizing the landscape of assisted reproduction. Preimplantation genetic testing exemplifies these advancements by enabling the detection of genetic disorders in embryos prior to implantation, offering parents greater reassurance. Furthermore, improvements in sperm freezing and thawing processes provide patients with enhanced options and flexibility. This focus on technological advancement is driving market growth, fostering more personalized treatment protocols, and significantly improving success rates in artificial insemination procedures.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Trade Analysis

Global Artificial Insemination Market Size by Type & CAGR (2026-2033)

• Intrauterine Insemination
• Intracervical Insemination
• Intravaginal Insemination
• Intratubal Insemination

Global Artificial Insemination Market Size by Source Type & CAGR (2026-2033)

• AIH-Husband
• AID-Donor

Global Artificial Insemination Market Size by End User & CAGR (2026-2033)

• Fertility clinics & other facilities
• Home

Global Artificial Insemination Market Size by Region & CAGR (2026-2033)

• North America, (Type, Source, End User)
  • US
  • Canada
• Europe, (Type, Source, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Type, Source, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Type, Source, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Type, Source, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Genea Pty Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rinovum Women's Health, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pride Angel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HI-TECH SOLUTIONS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kitazato Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rocket Medical plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Conceivex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genus plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABS Global
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Continental Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Select Series
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporations
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agtech inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imv Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TenderNeeds Fertility LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation